NNovo Nordisk Read More Novo Nordisk’s Oral Wegovy Wins Patient Preference as Long-Term Efficacy Data Strengthens Case2026-05-15 84% of patients prefer Novo Nordisk’s oral Wegovy over Lilly’s pill, with 14x lower dropout rate. Phase 3…
